Cancer Center in Boston to Sell $115M of Debt
- MassHEFA to Sell $214 Million for Two Cancer Facilities. Kaske, Michelle // Bond Buyer;1/17/2007, Vol. 359 Issue 32548, p36
The article reports on the plan of the Massachusetts Health and Educational Facilities Authority to issue 214 million of bonds on behalf of two hospitals to finance cancer-treatment facilities in the Boston, Massachusetts area. 150 million dollars will be given to the Dana-Farber Cancer...
- State probe shows Dana-Farber failed to follow basic protocols. Morrissey, John // Modern Healthcare;6/19/95, Vol. 25 Issue 25, p82
Reports on the Massachusetts Department of Public Health's investigation of Dana-Farber Cancer Institute's basic protocols for a potent experimental chemotherapy. Death and serious injuries of patients due mistakes in the administration of dosages; Pharmacists and nurses' errors; Investigation...
- State investigators cite cancer center's errors. // Modern Healthcare;6/5/95, Vol. 25 Issue 23, p24
Reports on the findings of a state investigation on Dana-Farber Cancer Institute in Boston, Mass. in relation to the pattern of errors committed by the hospital staff and medical personnel. Death of a patient and severe heart damage due to chemotherapy; Resignation of hospital personnel after...
- Dana-Farber cleared for Medicare funds. // Modern Healthcare;8/7/95, Vol. 25 Issue 32, p6
Reports the continuation of Medicare funds to the Dana-Farber Cancer Institute in Boston which was earlier canceled due to the death of a patient. Clearance from HCFA; Note on the death case.
- Three Boston hospitals agree to combine cancer programs. Morrissey, John // Modern Healthcare;1/22/96, Vol. 26 Issue 4, p16
Reports that Boston, Massachusetts-based Dana-Farber Cancer Institute, Massachusetts General Hospital and Brigham & Women's Hospital has agreed to combine cancer programs. Terms of the partnership agreement; Expected benefits on the merger of the programs; Comments from B.D. Colen, a...
- In case you haven't heard... // Primary Care Weekly;7/22/96, Vol. 2 Issue 29, p8
Reports on Boston, Massachusetts-based Dana-Farber Cancer Institute's recommendation that policymakers not move hastily toward doctor-assisted suicide in the United States.
- A mess at the best. Brink, Susan // U.S. News & World Report;6/12/95, Vol. 118 Issue 23, p10
Focuses on an investigation of the Dana-Farber Cancer Institute in Boston, Massachusetts. Report which outlined dozens of errors at the cancer center, including the absence of an adequate quality-assurance system to catch patterns of errors before they become terrible mistakes; Instances in...
- Elite cancer center gave journalist fatal drug dose. // Modern Healthcare;3/27/95, Vol. 25 Issue 13, p9
Reports on the death of health columnist Betsy Lehman of a mistaken drug dose at the Dana-Farber Cancer Institute in Boston, Massachusetts. Impact on the reputation of American hospitals; Comments from David M. Livingston, Dana-Farber's physician-in-chief.
- Cancer center's bonds unaffected by uproar. Pallarito, Karen // Modern Healthcare;4/3/95, Vol. 25 Issue 14, p14
Reports on the impact of a chemotherapy overdose of a Dana-Farber Cancer Institute patient on the sale of the center's bonds. Details on the death of the patient, Betsy Lehman; Response of investors; Measures to determine a bond issuer's creditworthiness.